Abbott latest to report pandemic recovery in Q2 as procedures return, COVID-19 tests drag diagnostics

Abbott Laboratories on Thursday reported second-quarter sales of $10.2 billion, a 35% increase on an organic basis from a year ago, driven by medical devices and what the company characterized as a continued recovery from the impact of the COVID-19 pandemic.